NZ515041A - Nucleic acid immunization - Google Patents

Nucleic acid immunization

Info

Publication number
NZ515041A
NZ515041A NZ515041A NZ51504100A NZ515041A NZ 515041 A NZ515041 A NZ 515041A NZ 515041 A NZ515041 A NZ 515041A NZ 51504100 A NZ51504100 A NZ 51504100A NZ 515041 A NZ515041 A NZ 515041A
Authority
NZ
New Zealand
Prior art keywords
nucleic acid
acid immunization
antigen
immunization
eliciting
Prior art date
Application number
NZ515041A
Other languages
English (en)
Inventor
Dexiang Chen
James T Fuller
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of NZ515041A publication Critical patent/NZ515041A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NZ515041A 1999-04-21 2000-04-21 Nucleic acid immunization NZ515041A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13024999P 1999-04-21 1999-04-21
PCT/US2000/010766 WO2000063385A2 (en) 1999-04-21 2000-04-21 Nucleic acid immunization

Publications (1)

Publication Number Publication Date
NZ515041A true NZ515041A (en) 2004-03-26

Family

ID=22443785

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ515041A NZ515041A (en) 1999-04-21 2000-04-21 Nucleic acid immunization

Country Status (6)

Country Link
EP (1) EP1180150A2 (de)
JP (1) JP2002542264A (de)
AU (1) AU4479700A (de)
CA (1) CA2370646A1 (de)
NZ (1) NZ515041A (de)
WO (1) WO2000063385A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1392365A2 (de) * 2000-11-02 2004-03-03 Powderject Vaccines, Inc. Zusammensetzungen und therapeutische verwendung von polynukleotiden, die für tcr kodieren
CN1842349A (zh) * 2003-08-29 2006-10-04 安琪士摩奇株式会社 使用无针注射器进行皮肤疾病基因治疗
WO2006027244A2 (en) * 2004-09-10 2006-03-16 Bracco Imaging S.P.A. Paramagnetic metal polyamino complexes for mri visualization of internalized polynucleotides
WO2006133497A1 (en) * 2005-06-15 2006-12-21 Adelaide Research & Innovation Pty Ltd Combination treatment
WO2007087758A2 (es) * 2006-01-31 2007-08-09 Centro De Ingenieria Genetica Y Biotecnologia Mimotopos de polisacáridos capsulares de neisseria meningitidis y formulaciones farmacéuticas
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US11541110B2 (en) 2017-10-13 2023-01-03 The Research Foundation For The State University Of New York Comprehensive vaccine design for commensal disease progression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027435A1 (en) * 1993-06-01 1994-12-08 Life Technologies, Inc. Genetic immunization with cationic lipids
JP3221683B2 (ja) * 1994-01-21 2001-10-22 パウダージェクト ヴァクシンズ， インコーポレイテッド ガス駆動型遺伝子搬入装置
WO1997011605A1 (en) * 1995-09-28 1997-04-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Stimulation of cell-mediated immune responses by targeted particulate genetic immunization
GB9609125D0 (en) * 1996-05-01 1996-07-03 Smithkline Beecham Plc Novel compounds
US6204250B1 (en) * 1996-11-22 2001-03-20 The Mount Sinai Medical Center Of The City Of New York Immunization of infants

Also Published As

Publication number Publication date
JP2002542264A (ja) 2002-12-10
EP1180150A2 (de) 2002-02-20
CA2370646A1 (en) 2000-10-26
WO2000063385A2 (en) 2000-10-26
AU4479700A (en) 2000-11-02
WO2000063385A3 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
AU2002360331A8 (en) Egviii endoglucanase and nucleic acids encoding the same
WO1995029193A3 (en) Melanoma antigens
WO2003052055A3 (en) Egvii endoglucanase and nucleic acids encoding the same
NO973250L (no) Preparater for avlevering av antigener
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
WO2002064057A3 (en) Use of cell penetrating peptides to generate antitumor immunity
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
NZ515041A (en) Nucleic acid immunization
AU2002309259A1 (en) Improved polysaccharide and glycoconjugate vaccines_____________
GB0113798D0 (en) Antigens and vectors for vaccination
MXPA01008605A (es) Proteina de enlace del antigeno goodpasture.
DK1370284T3 (da) Bakteriofag-medieret immunisering
ATE285474T1 (de) Haemophilus adhäsionsproteinen
CO5280140A1 (es) Antigeno (c42) asociado a tumores
WO2002051237A3 (en) Helicobacter proteins, nucleic acids and uses thereof
WO2004056316A8 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
WO2002099039A3 (en) Peptides for chlamydophila pneumoniae vaccine and diagnosis
WO2002010379A3 (en) Modified cea and uses thereof
NZ606260A (en) Novel polypeptides involved in immune response
BR0303226A (pt) Proteìnas de aderência e penetração de haemophilus
NZ334582A (en) Polyprotein construct of a papillomavirus

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed